Teva Pharmaceutical Industries Ltd

UNITED CAPITAL FINANCIAL ADVISORS, LLC TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

34,411

Value ($000)

1,074

Weight

0.0%

2013 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,074	0.0%	34,411	12/31/2025
2025 Q3	11/14/2025	693	0.0%	34,293	9/30/2025
2025 Q2	8/11/2025	576	0.0%	34,372	6/30/2025
2025 Q1	5/13/2025	540	0.0%	35,116	3/31/2025
2024 Q4	2/13/2025	734	0.0%	33,283	12/31/2024
2024 Q3	11/12/2024	595	0.0%	33,018	9/30/2024
2024 Q2	8/14/2024	610	0.0%	37,531	6/30/2024
2024 Q1	5/15/2024	545	0.0%	38,606	3/31/2024
2020 Q1	8/11/2020	118	0.0%	13,116	3/31/2020
2019 Q4	2/14/2020	114	0.0%	11,632	12/31/2019
2019 Q3	2/14/2020	78	0.0%	11,392	9/30/2019
2014 Q1	5/14/2014	552	0.0%	10,445	3/31/2014
2013 Q4	2/20/2014	272	0.0%	6,788	12/31/2013